home / stock / achv / achv news


ACHV News and Press, Achieve Life Sciences Inc. From 05/17/23

Stock Information

Company Name: Achieve Life Sciences Inc.
Stock Symbol: ACHV
Market: NASDAQ
Website: achievelifesciences.com

Menu

ACHV ACHV Quote ACHV Short ACHV News ACHV Articles ACHV Message Board
Get ACHV Alerts

News, Short Squeeze, Breakout and More Instantly...

ACHV - Achieve Life Sciences refinances outstanding loan

2023-05-17 10:16:29 ET Pharmaceutical company Achieve Life Sciences ( NASDAQ: ACHV ) said on Wednesday that it has refinanced an outstanding loan. The loan is a the part of a previous debt agreement with Silicon Valley Bank, a division of First-Citizens Bank. The new ...

ACHV - Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank

SEATTLE and VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced the C...

ACHV - Achieve Life Sciences, Inc. (ACHV) Q1 2023 Earnings Call Transcript

2023-05-09 22:02:06 ET Achieve Life Sciences, Inc. (ACHV) Q1 2023 Earnings Conference Call May 09, 2023, 04:30 PM ET Company Participants Nicole Jones - Investor Relations John Bencich - Chief Executive Officer Cindy Jacobs - President and Chief Medical Officer ...

ACHV - Achieve Life Sciences GAAP EPS of -$0.50 beats by $0.19

2023-05-09 17:02:03 ET Achieve Life Sciences press release ( NASDAQ: ACHV ): Q1 GAAP EPS of -$0.50 beats by $0.19 . As of March 31, 2023, the Company’s cash, cash equivalents, and restricted cash was $16.6 million. Shares +1.02% AH. For further det...

ACHV - Achieve Life Sciences Reports Financial Results for First Quarter 2023 and Provides Corporate Update

SEATTLE and VANCOUVER, British Columbia, May 09, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced first...

ACHV - Achieve Life Sciences Q1 2023 Earnings Preview

2023-05-08 17:35:58 ET Achieve Life Sciences ( NASDAQ: ACHV ) is scheduled to announce Q1 earnings results on Tuesday, May 9th, after market close. The consensus EPS Estimate is -$0.69 Over the last 3 months, EPS estimates have seen 2 upward revisions and 0 downwar...

ACHV - Notable earnings after Tuesday's close

2023-05-08 17:35:56 ET Major earnings expected after the bell on Tuesday include: Airbnb ( ABNB ) Occidental Petroleum Corporation ( OXY ) Twilio ( TWLO ) Virgin Galactic Holdings ( SPCE ) Upstart Holdings ( UPST ) For further details see: ...

ACHV - Achieve Life Sciences Inc. (NASDAQ: ACHV) Climbs to New 52-Week High

Shares of Achieve Life Sciences, Inc. (NASDAQ: ACHV) traded at a new 52-week high today and are currently trading at $8.42. So far today, approximately 47,759 shares have been exchanged, as compared to an average 30-day volume of 187.2k shares. Achieve Life Sciences, Inc., a clinical-stage ph...

ACHV - Achieve Life Sciences to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 9, 2023

SEATTLE and VANCOUVER, British Columbia, April 26, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today anno...

ACHV - Achieve: Late-Stage Biotech Developing Vaping And Smoking Cessation Drugs

2023-04-25 16:37:49 ET Summary Positive Phase 2 ORCA-V1 trial results show cytisinicline's potential in helping users quit vaping, with an odds ratio of 2.6 compared to placebo, suggesting a strong case for FDA approval. Cytisinicline demonstrated a favorable safety profile with n...

Previous 10 Next 10